Morpholine

Morpholine

SCHEMBL7748831

C1COCCN1.CCCn1cncc1-c1ccncc1

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 7/20 0.42
CYP11B2 P19099 7/20 0.42
PKN2 Q16513 4/20 0.39
PKN1 Q16512 3/20 0.39
MAPK13 O15264 3/20 0.35
MAPK12 P53778 3/20 0.35
MAPK11 Q15759 3/20 0.35
MAPK14 Q16539 3/20 0.35
IDO1 P14902 2/20 0.35
TDP1 Q9NUW8 1/20 0.34
BRD9 Q9H8M2 1/20 0.33
CDC7 O00311 2/20 0.33
NFATC1 O95644 1/20 0.33
GSK3B P49841 1/20 0.33
DYRK1A Q13627 1/20 0.33
ADRB2 P07550 1/20 0.33
NCF1 P14598 1/20 0.33
PLD1 Q13393 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7748830 0.74 NFATC1 (0.58) MAPK13MAPK12MAPK11MAPK14NFATC1
SCHEMBL1502091 0.73 CYP11B1 (0.62) CYP11B1CYP11B2IDO1BRD9
SCHEMBL27550009 0.72 CYP11B1 (0.56) CYP11B1CYP11B2IDO1
SCHEMBL10989195 0.70 IDO1 (0.46) CYP11B1CYP11B2IDO1
SCHEMBL1501997 0.66 IDO1 (0.51) CYP11B1CYP11B2IDO1
Morpholine SCHEMBL6137775 0.65 MEN1 (0.44) TDP1ADRB2NCF1PLD1
SCHEMBL7076732 0.65 CYP11B1 (0.43) CYP11B1CYP11B2MAPK13MAPK12MAPK11
SCHEMBL593796 0.64 CYP11B1 (0.58) CYP11B1CYP11B2IDO1BRD9
SCHEMBL27984310 0.63 CYP11B1 (0.51) CYP11B1CYP11B2IDO1
SCHEMBL4593524 0.62 MAPK13 (0.42) CYP11B1CYP11B2MAPK13MAPK12MAPK11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0906099-A4 A METHOD OF TREATING CANCER MERCK & CO INC (US) 2001-02-07 EP claimed
EP-0906099-A1 A METHOD OF TREATING CANCER Merck & Co., Inc. (US) 1999-04-07 EP claimed
WO-1997036587-A1 A METHOD OF TREATING CANCER MERCK & CO., INC. (US) 1997-10-09 WO claimed